- ABOUT GENEDX
- TESTS OFFERED
- SEND A SPECIMEN
- ORDER BUCCAL KITS
- FINANCIAL POLICY
- PRICES & CPT CODES
- SUGGEST A TEST!
- CONTACT US



![]() |
![]() |
The prevalence of mitochondrial disorders has been estimated at 1/5000 - 1/8500.
Mitochondrial disorders are clinically heterogeneous and result from dysfunction of the mitochondrial respiratory chain, which can be caused by mutations in mitochondrial DNA (mtDNA) or in nuclear genes. Mitochondrial disorders may affect a single organ, but many involve multiple organ systems particularly those that are highly dependent on aerobic metabolism (brain, skeletal muscle, heart, kidney and endocrine system). Patients may present at any age. Often the clinical features are highly variable and non-specific and many affected persons do not fit into one particular category. Recently, it has been estimated that approximately 7% of patients diagnosed with autism may have an underlying disorder of mitochondrial function.
Special Considerations for Mitochondrial Disorders: (See Test Information Sheet for additional details)
Testing is performed on mitochondrial and genomic DNA obtained from a blood or other tissue sample. While mutations in nuclear genes are easily detectable from a blood specimen, some mtDNA mutations may be undetectable in blood cells. A blood sample and tissue biopsy from the patient are preferable for the testing panel. POLG seqeuencing can be performed on blood or other tissue.
Specimen requirements are described below. Please call for additional information.
Sample Submission Form (Includes payment options and consent form)
Test Information Sheets (Include prices and CPT codes):
Mitochondrial Disorder deletion/duplication panel for mtDNA and 116 nuclear genes and 16 Common mtDNA point mutations
List of Nuclear Genes on Deletion/Duplication Panel
POLG sequencing